Transforming Discoveries
Our Bio
Our scientific, pathology, and regulatory teams have the experience needed to propel novel drug discoveries and the development of companion diagnostics.
Expertise
- 01 Hematopathology
- 02 Solid Tumor Pathology
- 03 Minimal Residual Disease (MRD)
- 04 Companion Diagnostics (CDx)
- 05 Next-Generation Sequencing (NGS)
- 06 Immuno-Oncology
Our laboratories feature the most advanced instruments available.
We continuously invest in state-of-the-art technologies to provide the highest quality of data to our clients.
01
Flow Cytometry
02
Molecular Genetics
03
Cytogenetics / FISH
04
Histology / IHC
05
Immunoassays & Clinical Chemistry
06
Digital Pathology
Clinical Trials
Hematogenix's mission is to assist pharma companies bring novel treatments from bench to bedside.
Our use of cutting-edge technologies, highly sensitive assays, and interpretation from expert pathologists provides a level of quality that is required to accentuate the efficacy of a novel therapeutic.
Propelling Cancer Diagnostics & Treatments
- Pathology Services
- Test Offering
- Assay Development
Propelling Cancer Diagnostics & Treatments
- CAP-Accredited
- CLIA-Certified
- ISO/IEC 27001:2013 Certified
- GCP-Compliant
- A Global Reference Laboratory
Our Pathologists are world-renowned, with expertise in several subspecialties
Our Pathologists are available to serve as Principal Investigators and Consultants
Our Pathologists are also employed full-time and at all of our global locations